Healthcare Market Research Reports

This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, ...

This article explains in detail the various challenges that confront the generic drug manufacturers in the global generic pharmaceuticals market. The defense strategies adopted by branded pharmaceutical companies to delay generic versions of their products have also been discussed. Strategic recommendations for the success of global generic compani...

The research service examines the image-guided and robot-assisted surgery market in Western Europe, covering the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The analysis includes market dynamics, revenue forecasts, market share, and competitive structure. The market has been segmented as: surgical imaging systems (SIS),...

This market insight provides a detialed explaination of the key challenges confronting existing industry participants and deterring new entrants in the European human growth hormones market. The key product differentiation strategies adopted by companies have been highlighted and discussed in depth with examples.

This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...

This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

This research service analyses various aspects of the computed and digital radiography market in Europe between 2010 and 2016. The market is divided into two segments: computed radiography and digital radiography. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, ...

This market insight compares and contrasts the various hypotheses postulated based on Alzheimers disease-modifying drug candidates under investigation in clinical trials. The mechanisms based on the two hallmark features of the disease, namely beta-amyloid and tau protein, have been analysed in detail. A brief overview of the other range of disease...